Comparing magnesium sulphate and dexmedetomidine in addition to bupivacaine in TAP block using ultrasound for pregnant women posted for LSCS

Not Applicable

• Conditions: Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium

• Registration Number: CTRI/2023/06/054383
• Lead Sponsor: CHETTINADACADEMYOFRESEARCHANDEDUCATIO

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 June 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Elective and emergency caesarean section

ASA - II and III

Exclusion Criteria

Age : < 18 years and > 40 years of age

Patient refusal

Allergic to Local anaesthetic

Bleeding disorder

Parturients who is already on MgSO4 for Pre-eclampsia / Eclampsia

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
This study will be used to compare the duration of post â?? operative analgesia between magnesium sulphate and dexmedetomidine added to bupivacaine in TAP block in LSCS patientsTimepoint: Baseline, 2 hours , 4 hours , 6 hours , 8 hours , 12 hours , 18 hours and 24 hours

Secondary Outcome Measures

Name	Time	Method
To assess sedation using Modified Ramsay Sedation ScaleTimepoint: 0 , 2 , 4 , 6 , 8 , 12 , 18 & 24 hours post-operatively;To assess the Intensity of post- operative pain , Haemodynamic status & side effects of parturients over 24 hours post- opertivelyTimepoint: 0 , 2 , 4 , 6 , 8 , 12 , 18 & 24 hours post-operatively;To assess the total requirement of rescue analgesia over a period of 24 hours post-operativelyTimepoint: 0 , 2 , 4 , 6 , 8 , 12 , 18 & 24 hours post-operatively